Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ebola Disease”

Showing 20 of 0 results

Early research (Phase 1)Ended earlyNCT01518881
What this trial is testing

Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion

Who this might be right for
Ebola Virus Infection
Arbutus Biopharma Corporation 24
Not applicableStudy completedNCT03098862
What this trial is testing

PREVAIL VI: Identification of Host Genetic Factors Underlying Ebola Virus Disease Risk, Mortality, Long-term Sequelae, Viral RNA Persistence, Humoral Immunity, and Ebola Vaccine Response

Who this might be right for
Ebola Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 4,830
Testing effectiveness (Phase 2)Study completedNCT02548078
What this trial is testing

Evaluate the Safety and Immunogenicity of a Candidate Ebola Vaccine in Children

Who this might be right for
Virus Diseases
GlaxoSmithKline 600
Testing effectiveness (Phase 2)UnknownNCT02380625
What this trial is testing

Multiple Treatments for Ebola Virus Disease (EVD)

Who this might be right for
Ebola Virus Disease
Clinical Research Management, Inc. 150
Large-scale testing (Phase 3)Study completedNCT02509494
What this trial is testing

Staged Phase 3 Study to Assess the Safety and Immunogenicity of Ebola Candidate Vaccines Ad26.ZEBOV and MVA-BN-Filo

Who this might be right for
Ebola Virus Disease
Janssen Vaccines & Prevention B.V. 1,023
Large-scale testing (Phase 3)Study completedNCT02503202
What this trial is testing

Evaluation of the Safety and Immunogenicity of Three Consistency Lots and a High-Dose Lot of rVSV-ZEBOV-GP (V920 Ebola Vaccine) in Healthy Adults (V920-012)

Who this might be right for
Prevention of Ebola Infection
Merck Sharp & Dohme LLC 1,197
Large-scale testing (Phase 3)WithdrawnNCT02307591
What this trial is testing

Clinical Study to Assess Efficacy and Safety of Amiodarone in Treating Patients With Ebola. Virus Disease (EVD) in Sierra Leone. EASE (EMERGENCY Amiodarone Study Against Ebola)

Who this might be right for
Ebola Virus Disease
Emergency NGO Onlus
Not applicableStudy completedNCT03140774
What this trial is testing

Persistence of the Immune Response After Immunisation With Ebola Virus Vaccines

Who this might be right for
Ebola Virus Disease
University of Oxford 126
Not applicableStudy completedNCT03309020
What this trial is testing

PREVAIL VII: Cataract Surgery in Ebola Survivors

Who this might be right for
Cataract
National Eye Institute (NEI) 37
Testing effectiveness (Phase 2)Study completedNCT03333538
What this trial is testing

Randomized Placebo-controlled Study of Safety and Immunogenicity of GamEvac-Lyo

Who this might be right for
Healthy Volunteers
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 220
Not applicableNot Yet RecruitingNCT07681752
What this trial is testing

Clinical Validation of Isothermal Nucleic Acid Amplification Bioassays Modules - GUINEA

Who this might be right for
Ebola Hemorrhagic FeverLassa Hemorrhagic Fever
Institute of Tropical Medicine, Belgium 150
Testing effectiveness (Phase 2)WithdrawnNCT04268966
What this trial is testing

An Open-Label Study , Safety and Tolerability of Brincidofovir for Post Exposure Prophylaxis of Ebola

Who this might be right for
Ebola Virus Disease
Jazz Pharmaceuticals
Early research (Phase 1)Study completedNCT02374385
What this trial is testing

Phase I Trial to Assess the Safety, Tolerability and Immunogenicity of a Ebola Virus Vaccine

Who this might be right for
Ebola Viruses
Dalhousie University 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT06100913
What this trial is testing

Immunology of Ebola Vaccine

Who this might be right for
Ebola Virus Disease
Emory University 30
Testing effectiveness (Phase 2)Study completedNCT05064956
What this trial is testing

Ad26.ZEBOV Booster in HIV+ Adults Previously Vaccinated With Ad26.ZEBOV/MVA-BN-Filo (EBOVAC HIV+ Booster Study)

Who this might be right for
Ebola Virus DiseaseEbolaHiv
London School of Hygiene and Tropical Medicine 26
Large-scale testing (Phase 3)Ended earlyNCT02661464
What this trial is testing

Long-term Safety Follow-up of Participants Exposed to the Candidate Ebola Vaccines Ad26.ZEBOV and/or MVA-BN-Filo

Who this might be right for
Hemorrhagic Fever, Ebola
Janssen Vaccines & Prevention B.V. 677
Early research (Phase 1)Study completedNCT00997607
What this trial is testing

Evaluating an Ebola and a Marburg Vaccine in Uganda

Who this might be right for
Ebola Virus DiseaseMarburg Virus Disease
National Institute of Allergy and Infectious Diseases (NIAID) 108
Early research (Phase 1)UnknownNCT04717830
What this trial is testing

An Open Study of the Safety and Pharmacokinetics of a Drug for the Emergency Prevention of Ebola Virus Disease

Who this might be right for
Ebola Virus Disease
Gamaleya Research Institute of Epidemiology and Microbiology, Health Ministry of the Russian Federation 25
Testing effectiveness (Phase 2)UnknownNCT04822376
What this trial is testing

Prophylaxis Vaccine Antibodies Ebola

Who this might be right for
Ebola Virus Disease
ANRS, Emerging Infectious Diseases 250
Early research (Phase 1)Study completedNCT02314923
What this trial is testing

Placebo Controlled, Dose Response, Safety and Immunogenicity Study of Vesicular Stomatitis Virus (VSV) Ebola Vaccine in Healthy Adults (V920-004)

Who this might be right for
Ebola Virus
Merck Sharp & Dohme LLC 513
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation